Saturday 17 October 2026
Export AVNT’s income statement to Excel — free account
Avient Corporation
AVNT Basic Materials Specialty Chemicals
Avient Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 0.61% from fiscal 2024. In the quarter to June 2026, revenue grew 5.83%, EPS grew 24.6%, free cash flow fell 16.7% and total debt fell 7.16%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
38.98
0.02
−0.05%
Follow AVNT
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 22.35 | 31.68 | 26.16 | 24.47 | 8.69 | 36.69 | 27.65 | 27.73 | 35.50 | 27.48 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 38.41 | 46.79 | 47.48 | 37.33 | 40.96 | 61.46 | 58.60 | 44.74 | 54.68 | 44.78 | |||||
| People | |||||||||||||||
| People | Employees | 7,000 | 6,300 | 6,600 | 5,600 | 8,400 | 8,700 | 9,700 | 9,300 | 9,200 | 9,000 | ||||
| Revenue/emp, $m | 0.42 | 0.41 | 0.44 | 0.51 | 0.26 | 0.38 | 0.35 | 0.34 | 0.35 | 0.36 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 2,939 | 2,590 | 2,881 | 2,863 | 2,215 | 3,316 | 3,397 | 3,143 | 3,240 | 3,260 | ||||
| Gross margin, % | 23.02 | 23.02 | 21.69 | 22.96 | 29.80 | 28.47 | 25.99 | 28.40 | 32.61 | 31.15 | |||||
| EBT | 227 | 112 | 102 | 109 | 61 | 204 | 64 | 87 | 225 | 112 | |||||
| EBT margin, % | 7.71 | 4.32 | 3.53 | 3.82 | 2.76 | 6.14 | 1.88 | 2.78 | 6.94 | 3.43 | |||||
| Net income | 165 | (58) | 160 | 589 | 133 | 231 | 703 | 76 | 171 | 84 | |||||
| Depreciation | 106 | 98 | 92 | 88 | 126 | 147 | 198 | 189 | 180 | 186 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 35.03 | 31.78 | 36.15 | 37.08 | 24.58 | 36.27 | 37.25 | 34.50 | 35.49 | 35.63 | ||||
| Earnings | 1.97 | (0.71) | 2.01 | 7.62 | 1.46 | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 | |||||
| Cash flow | 2.71 | 2.48 | 3.18 | 3.90 | 2.46 | 2.56 | 4.37 | 2.21 | 2.81 | 3.30 | |||||
| Capex | (1.00) | (0.98) | (0.90) | (1.06) | (0.71) | (1.10) | (1.16) | (1.31) | (1.34) | (1.16) | |||||
| Free cash flow | 1.71 | 1.51 | 2.28 | 2.84 | 1.75 | 1.46 | 3.21 | 0.90 | 1.48 | 2.13 | |||||
| Book value | 8.65 | 7.35 | 6.78 | 13.64 | 19.00 | 19.59 | 25.80 | 25.66 | 25.52 | 26.08 | |||||
| Shares, m | 84 | 82 | 80 | 77 | 90 | 91 | 91 | 91 | 91 | 92 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 16.55 | 0.00 | 14.30 | 4.82 | 27.59 | 22.11 | 4.40 | 49.54 | 21.97 | 35.10 | ||||
| P/S | 0.93 | 1.39 | 0.79 | 0.99 | 1.64 | 1.54 | 0.91 | 1.19 | 1.15 | 0.88 | |||||
| P/B | 3.75 | 6.00 | 4.22 | 2.70 | 2.12 | 2.86 | 1.32 | 1.60 | 1.60 | 1.20 | |||||
| EV/Sales | 1.28 | 1.80 | 1.20 | 1.12 | 2.19 | 1.92 | 1.36 | 1.68 | 1.62 | 1.31 | |||||
| EV/FCF | 26.17 | 37.96 | 19.03 | 14.63 | 30.73 | 47.83 | 15.83 | 64.24 | 38.94 | 21.90 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 228 | 202 | 254 | 301 | 222 | 234 | 398 | 202 | 257 | 302 | ||||
| Capex | (84) | (80) | (72) | (82) | (64) | (101) | (105) | (119) | (122) | (107) | |||||
| Free cash flow | 143 | 123 | 182 | 219 | 158 | 133 | 293 | 82 | 135 | 195 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 440 | 496 | 441 | 811 | 801 | 886 | 700 | 634 | 666 | 555 | ||||
| Total debt | 1,258 | 1,309 | 1,356 | 1,229 | 1,873 | 1,859 | 2,179 | 2,080 | 2,067 | 1,923 | |||||
| Net debt | 1,032 | 1,065 | 1,185 | 365 | 1,223 | 1,258 | 1,538 | 1,534 | 1,523 | 1,413 | |||||
| Shareholders’ equity | 726 | 599 | 541 | 1,053 | 1,712 | 1,791 | 2,353 | 2,338 | 2,330 | 2,386 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 6.20 | (2.12) | 5.89 | 19.63 | 3.23 | 4.68 | 12.69 | 1.26 | 2.88 | 1.38 | ||||
| ROIC | 9.52 | 6.50 | 6.47 | 6.91 | 2.38 | 5.73 | 3.91 | 3.18 | 5.34 | 3.35 | |||||
| ROE | 23.09 | (8.71) | 28.04 | 73.88 | 9.52 | 13.18 | 33.94 | 3.23 | 7.26 | 3.47 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Avient Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CLMT Calumet, Inc. | $5.1B | — (loss-making) | — (loss-making) | +40.77% (above 0%: growing) | n/m | +450.65% (above 0%: growing) | 1.27% | (2.77%) | Compare |
| PRM Perimeter Solutions, SA | $4.5B | — (loss-making) | 14.0× | +31.46% (above 0%: growing) | n/m | +56.62% (above 0%: growing) | 55.13% | (94.95%) | Compare |
| CBT Cabot Corporation | $3.9B | 20.9× | 8.6× | +6.39% (above 0%: growing) | −93.58% (below 0%: shrinking) | −77.02% (below 0%: shrinking) | 18.74% | 9.98% | Compare |
| AVNT Avient Corporation | $3.6B | 21.0× | 14.0× | +5.83% (above 0%: growing) | +24.56% (above 0%: growing) | −16.67% (below 0%: shrinking) | 33.54% | 12.26% | |
| ASH Ashland Inc. | $3.3B | 62.4× | 24.9× | +7.34% (above 0%: growing) | n/m | +5.26% (above 0%: growing) | 34.21% | 8.65% | Compare |
| FUL H. B. Fuller Company | $2.8B | 14.1× | 16.8× | +5.17% (above 0%: growing) | +18.19% (above 0%: growing) | −58.41% (below 0%: shrinking) | 33.22% | 12.07% | Compare |
| HWKN Hawkins, Inc. | $2.8B | 33.8× | 36.3× | +7.64% (above 0%: growing) | −3.55% (below 0%: shrinking) | +30.29% (above 0%: growing) | 23.44% | 12.25% | Compare |
| KWR Quaker Houghton | $2.7B | 27.9× | 25.2× | +10.17% (above 0%: growing) | n/m | −43.19% (below 0%: shrinking) | 35.53% | 7.62% | Compare |
| WDFC WD-40 Company | $2.7B | 30.3× | 34.0× | +24.35% (above 0%: growing) | +45.45% (above 0%: growing) | −13.28% (below 0%: shrinking) | 56.59% | 20.67% | Compare |
| Median of peers | $3.0B | 29.1× | 24.9× | +8.90% | +7.32% | −4.01% | 33.72% | 9.32% |
Avient Corporation (AVNT) key facts
- Concern: Net income was $83.6 million, or $0.90 per share (basic), a net margin of 2.51%.
- Strength: Avient Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 0.61% from fiscal 2024.
- Avient Corporation (AVNT) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
- As of October 16, 2026, AVNT traded at $38.98, a market capitalization of $3.6 billion.
- At that price the stock trades at 21.0× trailing-twelve-month earnings and 1.1× sales; its P/E is higher than 64% of its own readings over the past ten years.
- Avient Corporation pays an annual dividend of $1.10 per share, a yield of 2.82%, with a payout ratio of 59.5%.
- Return on equity was 3.47% and debt-to-equity 0.77.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.67 (distress zone) for fiscal 2025.